Page last updated: 2024-08-18

methylergonovine and Heart Valve Diseases

methylergonovine has been researched along with Heart Valve Diseases in 2 studies

*Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE). [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baumann, MH; Hufeisen, SJ; McBride, A; Rauser, L; Roth, BL; Rothman, RB; Savage, JE1
Golbraikh, A; Grulke, CM; Hajjo, R; Huang, XP; Roth, BL; Setola, V; Tropsha, A1

Other Studies

2 other study(ies) available for methylergonovine and Heart Valve Diseases

ArticleYear
Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.
    Circulation, 2000, Dec-05, Volume: 102, Issue:23

    Topics: Dose-Response Relationship, Drug; Ergotamine; Fenfluramine; Heart Valve Diseases; Humans; Methylergonovine; Norfenfluramine; Receptors, Serotonin; Serotonin Antagonists

2000
Development, validation, and use of quantitative structure-activity relationship models of 5-hydroxytryptamine (2B) receptor ligands to identify novel receptor binders and putative valvulopathic compounds among common drugs.
    Journal of medicinal chemistry, 2010, Nov-11, Volume: 53, Issue:21

    Topics: Algorithms; Binding, Competitive; Databases, Factual; Dexfenfluramine; Drug-Related Side Effects and Adverse Reactions; Fenfluramine; Heart Valve Diseases; Ligands; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Radioligand Assay; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT2 Receptor Agonists

2010